JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 40 No. 10 1652-1656
© 1999 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, N.
Right arrow Articles by Ochi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, N.
Right arrow Articles by Ochi, H.

Clinical Usefulness of Scintigraphy with 99mTc-Galactosyl-Human Serum Albumin for Prognosis of Cirrhosis of the Liver

Nobumitsu Sasaki, Susumu Shiomi, Yoshimori Iwata, Shuhei Nishiguchi, Tetsuo Kuroki, Joji Kawabe and Hironobu Ochi

Third Department of Internal Medicine and Division of Nuclear Medicine, Osaka City University Medical School, Osaka, Japan

Correspondence: For correspondence or reprints contact: Susumu Shiomi, MD, Third Department of Internal Medicine, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, 545-8585 Osaka, Japan.

ABSTRACT

Scintigraphy with 99mTc-diethylenetriamine pentaacetic acid-galactosyl-human serum albumin (99mTc-GSA) is useful for evaluating hepatic functional reserve. We assessed the clinical usefulness of this technique, including its value in establishing a prognosis, in patients with cirrhosis of the liver. Methods: Scintigraphy with 99mTc-GSA was performed in 10 healthy subjects, 42 patients with chronic hepatitis and 158 patients with cirrhosis. Computer acquisition of gamma camera data were started just before the injection of 99mTc-GSAT. Time-activity curves for the heart and liver were generated from regions of interest (ROIs) for the heart and the entire liver. A receptor index was calculated by dividing the radioactivity of the liver ROI by that of the liver-plus-heart ROI 15 min after the injection. An index of blood clearance was calculated by dividing the radioactivity of the heart ROI at 15 min by that of the heart ROI at 3 min. Results: The median receptor index was lower in patients with cirrhosis than in patients with chronic hepatitis or in healthy subjects, and the median index of blood clearance was higher. The receptor index was significantly lower when a complication (varices, ascites) was present. The index of blood clearance was significantly higher when a complication (varices and ascites) was present. Correlation of the two indices with classic indicators for functional reserve was significant. On the basis of the receptor index, the patients with cirrhosis were divided into two groups of roughly equal size: group A, receptor index over 0.85, and group B, receptor index 0.85 or less. On the basis of the index of blood clearance, the patients with cirrhosis were divided into two groups of roughly equal size: group A, index of blood clearance < 0.70, and group B, index of blood clearance ≥ 0.70. The cumulative survival rates were lower in group B than in group A. Conclusion: Scintigraphy with 99mTc-GSA is clinically useful, especially in establishing the prognosis of patients with cirrhosis of the liver.

Key Words: 99mTc-DTPA-galactosyl-human serum albumin • prognosis • cirrhosis of the liver




This article has been cited by other articles:


Home page
JNMHome page
W. de Graaf, R. L. Vetelainen, K. de Bruin, A. K. van Vliet, T. M. van Gulik, and R. J. Bennink
99mTc-GSA Scintigraphy with SPECT for Assessment of Hepatic Function and Functional Volume During Liver Regeneration in a Rat Model of Partial Hepatectomy
J. Nucl. Med., January 1, 2008; 49(1): 122 - 128.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E.-M. Kim, H.-J. Jeong, I.-K. Park, C.-S. Cho, C.-G. Kim, and H.-S. Bom
Hepatocyte-Targeted Nuclear Imaging Using 99mTc-Galactosylated Chitosan: Conjugation, Targeting, and Biodistribution
J. Nucl. Med., January 1, 2005; 46(1): 141 - 145.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1999 by the Society of Nuclear Medicine.